(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

HSF2 binds to the BZLF1 promoter and remodels the chromatin locally. by Lorenza Cutrone (21144285)

Subjects:

Primers used in ChIP-PCR. by Lorenza Cutrone (21144285)

Subjects:

(A and B) ChIP-qPCR analysis of HSF2 binding to the indicated KSHV genomic regions expressed as % of input in KSHV infected latent (A) and lytic (B) cells. by Lorenza Cutrone (21144285)

Subjects:

Primers used in RTqPCR. by Lorenza Cutrone (21144285)

Subjects:

HSF2 expression sustains KSHV infection in KLEC. by Lorenza Cutrone (21144285)

Subjects:

(A–D) Representative immunoblots for the reporter assays shown in Fig 4A–D. by Lorenza Cutrone (21144285)

Subjects:

HSF2 is a positive regulator of EBV spontaneous lytic cycle in gastric epithelial cells. by Lorenza Cutrone (21144285)

Subjects:

HEK.219 cells were treated with the indicated siRNAs for 24h. by Lorenza Cutrone (21144285)

Subjects:

HSF2 regulates ORF50 expression in an RTA independent manner. by Lorenza Cutrone (21144285)

Subjects:

HSF2 is degraded during KSHV lytic reactivation. by Lorenza Cutrone (21144285)

Subjects:

(A) Confocal representative images and (B) quantification of the H3me3K4 integrated intensity in n > 100 cells in iSLK.219 either latent or induced to the lytic cycle with doxycycl... by Lorenza Cutrone (21144285)

Subjects:

HSF2 regulates lytic gene expression in latency and during the lytic phase. by Lorenza Cutrone (21144285)

Subjects:

HSF2 binds the ORF50 promoter and remodels the local chromatin landscape. by Lorenza Cutrone (21144285)

Subjects:

Metabolites with decreasing levels during the development. by Martin Sládek (130663)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

The level of miRNA 221 in the myocardium of MIRI mice was decreased. by Hongyu Li (1332669)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)